Author Archives: Meredith Mazzotta

High HIV rates in Asia-Pacific transgenders, trade deal threatens affordable AIDS meds abroad, and more…

By on .

The following list of What We’re Reading is a compilation of recent releases and reports making headlines in global health: HIV may afflict almost half Asia-Pacific transgenders (UN): According to a new report from the United Nations (UN), almost 50 percent of transgender people in the Asia-Pacific region could be HIV infected – with poor […]

Report: GeneXpert TB diagnostics take off in low-resource countries

By on .

As of the end of the first quarter of 2012, nearly 864,000 GeneXpert MTB/RIF rapid tuberculosis (TB) diagnostic cartridges had been procured under manufacturer Cephied’s concessional pricing mechanism. The information was part of a the three-page report released in May by the Stop TB Department of the World Health Organization (WHO), giving an update on […]

FDA advisory committee recommends approval of over-the-counter, at-home HIV test

By on .

The following is a guest blog post by HIV Medicine Association Policy Officer, Kimberly Crump.

The U.S. Food and Drug Administration’s (FDA’s) 17-member Blood Products Advisory Committee voted unanimously to recommended FDA approval of OraSure Technologies’ over-the-counter, in-home HIV test Tuesday. After a full day of presentations…

UNITAID seeks innovative HIV, TB and malaria proposals

By on .

UNITAID is inviting letters of intent (LOI), or short conceptual presentations of a proposed project, on the topic of improving access to key preventive, diagnostic and treatment commodities for HIV, tuberculosis (TB) and malaria through market-based approaches.  UNITAID works to negotiate low pricing for diagnostics and medication for AIDS, tuberculosis and malaria in developing countries […]

Why the world needs Robin: Advocates launch Robin Hood Tax Global Week of Action

By on .

A hodgepodge group of charities, green groups, trade unions, community organizations, celebrities, religious leaders and politicians are rallying this week to  bring global attention to a Financial Transaction Tax (FTT) meant to “reform Main Street” with a small tax on bank profits. The idea is to implement a tax of less than half of one […]

Updated: FDA committee recommends Truvada’s approval as PrEP

By on .

The U.S. Food and Drug Administration (FDA) Antiviral Drugs Advisory Committee recommended Thursday that the supplemental application for Gilead Sciences’ HIV drug Truvada (a combination of emtricitabine plus tenofovir, or TDF-FTC) as pre-exposure prophylaxis (PrEP) be approved for high-risk, HIV-negative individuals to reduce the risk of sexually acquired HIV infection. The panel of medical experts, […]

Global Fund announces additional $1.6 billion at its disposal through 2014

By on .

The Global Fund to Fight AIDS, Tuberculosis and Malaria estimates an additional $1.6 billion in funding will be available in the 2012-2014 period, according to a press release issued Wednesday by the organization. “The new forecast is a result of strategic decisions made by the Board, freeing up funds that can be invested in countries […]

PDPs agree to jointly develop new TB vaccine candidate

By on .

Aeras and the Infectious Disease Research Institute (IDRI) – two non-profit product development partnerships (PDPs) – announced Wednesday they will be joining together to develop IDRI’s novel tuberculosis (TB) vaccine candidate ID93/GLA-SE. The compound contains an IDRI-designed recombinant fusion-protein antigen (a protein substance foreign to the body that stimulates the immune system’s production of antibodies […]

Rwanda study: AIDS funding influx does not hurt response to other health issues

By on .

Despite fears that disproportionate resources devoted to HIV have crowded out other health services, global HIV/AIDS program funding does not subtract from other health issues, according to a study that appeared in the May edition of the American Journal of Tropical Medicine and Hygiene. Experts have disagreed over whether money injected into the global HIV/AIDS […]

PEPFAR releases report to Congress, an update on drug-resistant TB in India, and more…

By on .

The following “What We’re Reading” selection is a collection of articles, commentary and resources making headlines recently in global health news. PEPFAR releases 8th annual report to Congress: The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) program delivered its 8th annual report to Congress recently. The five-page document outlines the program’s progress as of […]